Table 3.
Metabolic pathway analysis.
S. no. | Pathways | P value | Holm p | FDR | Impact |
---|---|---|---|---|---|
1 | Phenylalanine, tyrosine and tryptophan biosynthesis | 0.074 | 1 | 0.215 | 1 |
2 | Phenylalanine metabolism | 0.074 | 1 | 0.215 | 0.35 |
3 | Biotin metabolism | 0.205 | 1 | 0.444 | 0.2 |
4 | Cysteine and methionine metabolism | 0.219 | 1 | 0.443 | 0.15 |
5 | Tyrosine metabolism | 0.118 | 1 | 0.285 | 0.13 |
6 | Alanine, aspartate and glutamate metabolism | 0.356 | 1 | 0.509 | 0.13 |
7 | Pentose and glucuronate interconversions | 0.002 | 0.07 | 0.019 | 0.10 |
8 | Vitamin B6 metabolism | 0.027 | 0.66 | 0.133 | 0.07 |
9 | Citrate cycle (TCA cycle) | 0.869 | 1 | 0.933 | 0.05 |
10 | Porphyrin metabolism | 0.975 | 1 | 0.975 | 0.05 |
Pathway analysis was performed using MetaboAnalyst 6.0. to identify pathways that were significantly altered after HA exposure. Here, p value: The original p value calculated from pathway analysis; Holm p: p values adjusted by the Holm–Bonferroni method; FDR, false discovery rate; Impact, represents a combination of the centrality and pathway enrichment result.